Alector, Inc. (ALEC)
1.28
+0.06
(+4.92%)
USD |
NASDAQ |
Dec 09, 16:00
1.27
-0.01
(-0.78%)
Pre-Market: 08:04
Alector EPS Diluted (Quarterly): -0.3379 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.2918 |
| Cocrystal Pharma, Inc. | -0.1864 |
| GlucoTrack, Inc. | -4.638 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.67M |
| Revenue (Quarterly) | 3.26M |
| Total Expenses (Quarterly) | 37.93M |
| Enterprise Value | -113.52M |
| Gross Profit Margin (Quarterly) | 28.47% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -83.62% |
| Normalized Earnings Yield | -82.45 |